InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by McClung David Mark, EVP, directeur commercial et COO. Director active across 1 company, notably Sangamo Therapeutics, INC. Aggregated, 8 filings have been published. Activity tracked since 25 June 2021. The latest transaction was disclosed on 25 November 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to McClung David Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
1,925 shares@ US$0.38210.2% of flowCommon StockSEC:0001209191-23-056788:0
1,925 shares@ US$0.770.4% of flowCommon StockSEC:0001209191-23-047586:0
11,528 shares@ US$1.193.9% of flowCommon StockSEC:0001209191-23-039711:0
1,925 shares@ US$1.330.7% of flowCommon StockSEC:0001209191-23-032910:0
56,250 shares0Common StockSEC:0001209191-23-016395:0
11,525 shares@ US$4.310.032% mcap15.5% of flowCommon StockSEC:0001209191-22-039649:0
4,610 shares@ US$5.9011.9% of flowCommon StockSEC:0001209191-22-014167:0
11,525 shares@ US$12.0256.7% of flowCommon StockSEC:0001209191-21-043811:0
8 of 8 declarations
About McClung David Mark
David Mark McClung is the EVP, Chief Business Officer, and COO at SANGAMO THERAPEUTICS, INC. He oversees the operations and business initiatives of the company.
